Related Experiment Videos

Identification of an efflux pump gene, pmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae

M J Gill1, N P Brenwald, R Wise

  • 1Division of Immunity and Infection, University of Birmingham Medical School, Birmingham B15 2TT, United Kingdom. m.j.gill@bham.ac.uk

Insights

Inactivating a norA-like gene in fluoroquinolone-resistant pneumococcus restored drug sensitivity. This suggests the gene encodes a major facilitator system pump.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Drug Resistance

Background:

  • Fluoroquinolone resistance in Streptococcus pneumoniae is a growing public health concern.
  • Efflux pumps play a significant role in multidrug resistance in bacteria.
  • The norA gene in Staphylococcus aureus is a well-characterized fluoroquinolone efflux pump.

Purpose of the Study:

  • To investigate the role of a norA-homologous open reading frame (ORF) in fluoroquinolone resistance in Streptococcus pneumoniae.
  • To determine if inactivation of this ORF could restore susceptibility to fluoroquinolones.

Main Methods:

  • Insertionally inactivated the norA-homologous ORF using the cat gene in a fluoroquinolone-resistant pneumococcal strain.
  • Assessed the resulting strain for fluoroquinolone susceptibility and efflux phenotype.
  • Performed sequence analysis to determine the putative function and class of the ORF product.

Main Results:

  • Inactivation of the norA-homologous ORF resulted in a complete reversion to fluoroquinolone sensitivity.
  • The identified ORF product shares 24% amino acid identity with NorA and Bmr, known multidrug efflux pumps.
  • The sequence homology suggests the ORF encodes a 12-transmembrane-segment major facilitator superfamily (MFS) transporter.

Conclusions:

  • The studied norA-homologous ORF is crucial for the fluoroquinolone resistance and efflux phenotype in this pneumococcal isolate.
  • This ORF likely encodes a novel MFS efflux pump contributing to antimicrobial resistance in Streptococcus pneumoniae.
  • Targeting such efflux pumps could be a viable strategy to combat fluoroquinolone resistance.

Related Concept Videos